Biofidelity raised $24m in funding from investors including Agilent Technologies, Octopus Ventures, BlueYard Capital, and Longwall Ventures.

Biotech Health services

United Kingdom

United States

Germany

Investments

05 March 2024

Share:

Biofidelity (company)

United Kingdom

Biotech Health services

Total investments received (USD): 59m

Round value (USD): 24m

Round investors: Agilent Technologies BlueYard Capital Longwall Ventures Octopus Ventures

Company: Biofidelity

Industry: Biotech Health services

Related deals

LoQus23 raised £35M series A led by Forbion Partners, joined by SV Health Investors, Novartis Venture Fund and Dementia Discovery Fund

Biotech Health services Manufacturing

United Kingdom

Netherlands

Switzerland

Investments 03 September 2024

Enara Bio raised $32.5m in Series B funding co-led by Pfizer Ventures and M Ventures, joined by RA Capital, Samsara BioCapital, and SV Health Investors.

Biotech Health services Pharma

United Kingdom

Netherlands

United States

Investments 03 September 2024

CellCentric raised £27.2M with RA Capital Management

Biotech Health services Manufacturing

United Kingdom

United States

Investments 19 July 2024

Yellowstone Biosciences raises £16.5M with Syncona Partners

Biotech Health services Pharma

United Kingdom

Investments 13 June 2024

LabGenius raised a $44.5M Series B round led by M Ventures, with Octopus Ventures, LG Corp, Atomico, Kindred Capital, Lux Capital, and Obvious Ventures

AI (big data) Biotech Health services

United Kingdom

South Korea

United States

Netherlands

Investments 12 May 2024